Skip to main content

Table 1

From: Induction strategy with enfuvirtide: results from the Fuziona study, a multicenter retrospective study in Spain

 

Rebounder n = 4

Non-Rebounder n = 37

Major PI mutations (median)

6

3

DRV or RAL or MVC in the regimen

0 (0%)

7 (19%)

TPV in the regimen

2 (50%)

7 (18,9%)

Total Time on T20 (median, months)

17,8

7